Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT00695032Not ApplicableSuspended
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
Chemotherapeutic Agent ToxicityRenal ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Cancer of KidneyMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Similarity Score18%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerCancer of Kidney
Similarity Score12%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificChemotherapeutic Agent Toxicity
Similarity Score12%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificMetastatic Cancer
Similarity Score12%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificCancer of Kidney
Similarity Score12%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Similarity Score12%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of KidneyUnspecified Adult Solid Tumor, Protocol Specific
Similarity Score12%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Related
12 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificMetastatic Cancer
Similarity Score12%

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of KidneyMetastatic Cancer
Similarity Score12%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00695032Not ApplicableStudyChair

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Chemotherapeutic Agent ToxicityRenal ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Suspended
NCT00814021Phase 2StudyChair

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Kidney CancerMetastatic Cancer
Completed

All 2 trials loaded